Triomics is a generative AI platform that matches patients to clinical trials by analyzing health records and medical terminology. This technology alleviates the cognitive overload faced by healthcare staff, accelerating trial enrollment and improving oncology care operations.
Funding
$37M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+2Founders
Product
Problem
Healthcare staff face cognitive overload due to the exponential growth of oncology data, making it difficult to efficiently match patients to relevant clinical trials. This challenge slows down trial enrollment and hinders the advancement of oncology research and care operations.
Solution
Triomics offers a generative AI platform designed to streamline patient matching for clinical trials by analyzing health records and medical terminology. The platform alleviates the burden on healthcare staff by automating the process of identifying suitable trials for patients. By leveraging AI, Triomics accelerates trial enrollment, facilitates quality improvement projects, and optimizes healthcare operations within oncology. The AI is trained to understand complex health records and medical terminology, ensuring accurate and reliable patient-trial matching.
Target Audience
The primary target audience includes cancer care providers, oncology researchers, and healthcare organizations seeking to improve trial enrollment and streamline oncology operations.
Features
- Generative AI-powered platform for analyzing health records and medical terminology
- Automated patient-trial matching to accelerate clinical trial enrollment
- Support for quality improvement projects in oncology
- Streamlined healthcare operations through AI-driven automation
- AI trained on oncology-specific data for accurate results